INITIAL AMINOGLYCOSIDE LEVELS IN THE CRITICALLY ILL

被引：49

作者：

SUMMER, WR

MICHAEL, JR

LIPSKY, JJ

机构：

[1] JOHNS HOPKINS MED INST, DEPT MED, BALTIMORE, MD 21205 USA

[2] JOHNS HOPKINS MED INST, DEPT PHARMACOL & ENVIRONM THERAPEUT, BALTIMORE, MD 21205 USA

[3] JOHNS HOPKINS MED INST, DEPT ANESTHESIOL & CRIT CARE MED, BALTIMORE, MD 21205 USA

来源：

CRITICAL CARE MEDICINE | 1983年 / 11卷 / 12期

关键词：

D O I：

10.1097/00003246-198312000-00011

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

收藏

页码：948 / 950

页数：3

相关论文

共 10 条

[1] ALEXANDER MR, 1982, AM REV RESPIR DIS, V125, P208
[2] GENTAMICIN IN 1978
APPEL, GB
NEU, HC
[J]. ANNALS OF INTERNAL MEDICINE, 1978, 89 (04) : 528 - 538
[3] WHY MONITOR SERUM LEVELS OF GENTAMICIN
BARZA, M
LAUERMANN, M
[J]. CLINICAL PHARMACOKINETICS, 1978, 3 (03) : 202 - 215
[4] ANTIBACTERIAL ACTIVITY IN SERUM AND URINE AS A THERAPEUTIC GUIDE IN BACTERIAL INFECTIONS
KLASTERS.J
DANEAU, D
SWINGS, G
WEERTS, D
[J]. JOURNAL OF INFECTIOUS DISEASES, 1974, 129 (02) : 187 - 193
[5] GRAM-NEGATIVE BACTEREMIA .4. RE-EVALUATION OF CLINICAL-FEATURES AND TREATMENT IN 612 PATIENTS
KREGER, BE
CRAVEN, DE
MCCABE, WR
[J]. AMERICAN JOURNAL OF MEDICINE, 1980, 68 (03) : 344 - 355
[6] EXPERIENCE IN MONITORING GENTAMICIN THERAPY DURING TREATMENT OF SERIOUS GRAM-NEGATIVE SEPSIS
NOONE, P
PARSONS, TMC
PATTISON, JR
SLACK, RCB
GARFIELD.D
HUGHES, K
[J]. BRITISH MEDICAL JOURNAL, 1974, 1 (5906) : 477 - 481
[7] CONTROLLED COMPARISON OF AMIKACIN AND GENTAMICIN
SMITH, CR
BAUGHMAN, KL
EDWARDS, CQ
ROGERS, JF
LIETMAN, PS
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (07) : 350 - 353
[8] WILKOWSKE CJ, 1983, MAYO CLIN PROC, V58, P6
[9] ZACKE OE, 1980, SURGERY, V87, P104
[10] ZASKE DE, 1980, APPLIED PHARMACOKINE, P210